Monogram Biosciences, Inc. (MGRM) Presents Its VeraTagTM Assays at EORTC-NCI-AACR Symposium
Monogram Biosciences, Inc., a California based leader in molecular diagnostics for improving drug treatment of serious diseases, today announced presentations made by its scientists related to the company’s VeraTag™ assays. The presentations were made at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Geneva, Switzerland. The presentations dealt with what are called EGFR/HER receptors, known to be significant to the proliferation of many different cancers, such as breast cancer. The presentations were about Monogram’s developments in the field of assays used for detecting these receptors in cancerous tissues, information that is critical for associated drug development and…